Subsequent in vitro and in vivo cell proliferation studies indicated that knockdown of ANXA1 blocked the effect of YTHDC1 on modulating the sensitivity of renal cancer cells to sunitinib (Fig. 6I M). This evidence concerns the gene ANXA1 and renal carcinoma.